Sle Nephrology Gr

SYSTEMIC LUPUS ERYTHEMATOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Systemic Lupus Erythematosus ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Mordern Era ,[object Object],[object Object],[object Object]

Demographics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Etiology & Pathogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

SLE: PREDISPOSING FACTORS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pathology ,[object Object],[object Object],[object Object],[object Object],[object Object]

ACR Criteria for Classification of SLE

PITFALLS IN DIAGNOSING SLE ,[object Object],[object Object],[object Object],[object Object],[object Object]

Manifestations of SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Organ systems involved ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Autoantibodies in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],COMMON ++++ +++ +

Conditions associated with ANA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Malar Rash ,[object Object],[object Object],[object Object],Systemic lupus erythematosus

[object Object],[object Object],[object Object],Systemic lupus erythematosus

Musculoskeletal Manifestations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Renal- You are the EXPERT ,[object Object],[object Object]

CNS MANIFESTATIONS OF SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

HEART AND SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

SLE & Atherosclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Atherosclerosis in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Acute presentation ,[object Object],[object Object],[object Object]

Diagnosis? ,[object Object],[object Object],[object Object]

PULMONARY MANIFESTATIONS IN SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

SHRINKING LUNG SYNDROME ,[object Object],[object Object],[object Object]

Hematologic Abnormalities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Antibodies associated with SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Autoantibodies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Drug induced SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

TREATMENT (cont.) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

“ Ideal” immunomodulatory Rx ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

When should immunosuppressive Rx be added to minimize prednisone use ? ( J. Rheumatol.2009;36:560-4 ) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INDICATIONS FOR HIGH DOSE STEROIDS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Mycophenolate Motefil Trial Schanz S, et al. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol. 2002 Jul;147(1):174-8.

New Developments in SLE Landscape ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object]

Sle Nephrology Gr

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (20)

Similar to Sle Nephrology Gr

Similar to Sle Nephrology Gr (20)

More from Tejas Desai

More from Tejas Desai (9)

Recently uploaded

Recently uploaded (20)

Sle Nephrology Gr

Editor's Notes